Trials / Conditions / Adult Primary Cholangiocellular Carcinoma
Adult Primary Cholangiocellular Carcinoma
6 registered clinical trials studyying Adult Primary Cholangiocellular Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery NCT01766219 | Wake Forest University Health Sciences | Phase 1 / Phase 2 |
| Withdrawn | Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duc NCT01859182 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest NCT01643499 | University of Chicago | Phase 1 |
| Terminated | Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers NCT01229111 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer NCT00033462 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | BMS-247550 in Treating Patients With Liver or Gallbladder Cancer NCT00023946 | National Cancer Institute (NCI) | Phase 2 |